0
Skip to Content
NMD Pharma
Home
About NMD Pharma
Management team
Our team
Board
Founders
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Information for patients
Spinal Muscular Atrophy
Myasthenia Gravis
Charcot-Marie-Tooth
Press releases
Events
Other news
Investors
Your career
Find your job
Contact
NMD Pharma
Home
About NMD Pharma
Management team
Our team
Board
Founders
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Information for patients
Spinal Muscular Atrophy
Myasthenia Gravis
Charcot-Marie-Tooth
Press releases
Events
Other news
Investors
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Patient insights
Scientific publications
Folder: Patients & Clinical Trials
Back
Information for patients
Spinal Muscular Atrophy
Myasthenia Gravis
Charcot-Marie-Tooth
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact
Muscular chloride channel inhibition improves neuromuscular function
Other news Stine Krag Brunvold 5/28/21 Other news Stine Krag Brunvold 5/28/21

Muscular chloride channel inhibition improves neuromuscular function

Read More
Sachs 4th Annual Neuroscience Innovation Forum
Other news Stine Krag Brunvold 4/29/21 Other news Stine Krag Brunvold 4/29/21

Sachs 4th Annual Neuroscience Innovation Forum

Read More
The first Oligonucleotides for CNS
Other news Stine Krag Brunvold 2/17/21 Other news Stine Krag Brunvold 2/17/21

The first Oligonucleotides for CNS

It all begins with an idea.

Read More
Aarhus Biotech Company takes up the fight against neuromuscular diseases</a>
Other news Stine Krag Brunvold 1/26/21 Other news Stine Krag Brunvold 1/26/21

Aarhus Biotech Company takes up the fight against neuromuscular diseases

It all begins with an idea.

Read More
NMD Pharma to Present at Neuromuscular Drug Development Summit</a>
Other news Stine Krag Brunvold 12/2/20 Other news Stine Krag Brunvold 12/2/20

NMD Pharma to Present at Neuromuscular Drug Development Summit

It all begins with an idea.

Read More
NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth
Press release Stine Krag Brunvold 11/30/20 Press release Stine Krag Brunvold 11/30/20

NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth

It all begins with an idea.

Read More
NMD Pharma Receives Grant from The Innovation Fund Denmark</a>
Press release Stine Krag Brunvold 11/30/20 Press release Stine Krag Brunvold 11/30/20

NMD Pharma Receives Grant from The Innovation Fund Denmark

It all begins with an idea.

Read More
NMD Pharma to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
Other news Stine Krag Brunvold 11/6/20 Other news Stine Krag Brunvold 11/6/20

NMD Pharma to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference

It all begins with an idea.

Read More
NMD Pharma Initiates Combined Phase I/II Clinical trial
Press release Stine Krag Brunvold 10/6/20 Press release Stine Krag Brunvold 10/6/20

NMD Pharma Initiates Combined Phase I/II Clinical trial

It all begins with an idea.

Read More
NMD Pharma begins first clinical trial
Press release Stine Krag Brunvold 7/15/20 Press release Stine Krag Brunvold 7/15/20

NMD Pharma begins first clinical trial

It all begins with an idea.

Read More
Welcome to Monique Schiersing and Roel Bulthuis as new BoD members
Other news Stine Krag Brunvold 5/27/20 Other news Stine Krag Brunvold 5/27/20

Welcome to Monique Schiersing and Roel Bulthuis as new BoD members

It all begins with an idea.

Read More
Prominent Canadian researcher in Denmark: Why I left a top job in California
Other news Stine Krag Brunvold 8/28/19 Other news Stine Krag Brunvold 8/28/19

Prominent Canadian researcher in Denmark: Why I left a top job in California

It all begins with an idea.

Read More
NMD Pharma picked as Biotech of the Week by Labiotech.eu
Other news Stine Krag Brunvold 12/17/18 Other news Stine Krag Brunvold 12/17/18

NMD Pharma picked as Biotech of the Week by Labiotech.eu

It all begins with an idea.

Read More
NMD Pharma raises €38M (USD 47 Million) SERIES A</a> Financing
Press release Stine Krag Brunvold 3/23/18 Press release Stine Krag Brunvold 3/23/18

NMD Pharma raises €38M (USD 47 Million) SERIES A Financing

It all begins with an idea.

Read More
Newer Posts

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn X Facebook Instagram